🇺🇸 ICS+LABA in United States

ICS+LABA (ICS+LABA) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

ICS+LABA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is ICS+LABA approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for ICS+LABA in United States?

Shanghai Pulmonary Hospital, Shanghai, China is the originator. The local marketing authorisation holder may differ — check the official source linked above.